WeVote
Log In

Bill

Bill

S 847

An Act relative to rapid whole genome sequencing

194th Legislature (2025-2026) Introduced by John Cronin

Massachusetts bill establishing rapid whole genome sequencing protocols to accelerate genetic diagnosis while addressing data privacy, clinical validation, and equitable patient access concerns.

Accompanied a study order, see S2931
0
WeVote Research Nonpartisan
Bill Summary · S 847

Legislative bill overview

S 847 establishes a framework for rapid whole genome sequencing (WGS) in Massachusetts, likely creating pathways for expedited genetic testing and clinical implementation. The bill appears designed to accelerate access to comprehensive genomic analysis for patients, particularly in critical care or diagnostic contexts where speed is essential.

Why is this important

Whole genome sequencing can identify genetic causes of rare diseases, inform treatment decisions, and improve diagnostic accuracy—potentially reducing the time patients spend in medical uncertainty. However, rapid implementation without proper safeguards could create challenges around data privacy, genetic counseling adequacy, and equitable access across different populations.

Potential points of contention

  • Privacy and data security: Rapid genomic data collection raises questions about how genetic information is stored, protected, and potentially used by insurers or employers
  • Clinical utility and oversight: Unclear standards for which conditions warrant rapid WGS and whether results are validated sufficiently before clinical use
  • Counseling and consent: Whether patients receive adequate genetic counseling before rapid sequencing, especially given the complexity of interpreting whole genome results
  • Cost and equity: Questions about insurance coverage, whether rapid WGS becomes available only to affluent patients, and impacts on healthcare costs

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.